Moderna vs Onco Access
Moderna vs Onco Access, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moderna is on 77/100 and Onco Access on 15/100.
Where each one leads
Moderna
- our overall score: 77/100 against 15/100
- agent readiness: 49/100 against 26/100
Onco Access
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Moderna | Onco Access |
|---|---|---|
| What it is | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. | OncoAccess provides a platform for oncology clinical trial matching and patient access. |
| Category | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals | HealthTech, MedTech, Clinical Trials, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2010 | 2023 |
| Headquarters | Cambridge, United States | New York, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Moderna | Onco Access |
|---|---|---|
| Employees | 6,297 | Not published |
| Open roles | 100 | Not published |
| Total funding | $4.5B | Not published |
| Latest round | Funding Round | Grant |
| LinkedIn followers | 780,086 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moderna | Onco Access |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 77/100 | 15/100 |
| Traction | 60/100 | Not published |
| Team | 70/100 | 30/100 |
| Community | 13/100 | Not published |
| Search visibility | 46/100 | 5/100 |
| Quality | 90/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 79/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moderna | Onco Access |
|---|---|---|
| Hosting | AWS | AWS |
| CDN | CloudFront | Cloudflare |
| Frameworks | Next.js | Not detected |
What users say
| Measure | Moderna | Onco Access |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 2.0/5 from 1 vote | Not published |
Moderna vs Onco Access: common questions
Which is better, Moderna or Onco Access?
On our 0-100 score Moderna rates higher (77/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Moderna and Onco Access compare on the numbers?
Moderna leads on our overall score (77/100 against 15/100), agent readiness (49/100 against 26/100).
Read the full Moderna review and pricing or the Onco Access review and pricing. You can also browse other Moderna alternatives we track.